CV/COS Webinar: Clip 16

During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.

Recent Episodes

The Rothman Index, developed by Dr. Michael Rothman and his brother Steven, is a pioneering patient acuity score designed to help clinicians recognize patient deterioration earlier and more clearly. Presented as an easily understood, color-coded graph that updates in real time, the Index displays upward and downward trends in patient condition at a glance—transforming…

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risks can go unnoticed. The central challenge facing hospitals today is not…